Pansari Developers Limited

The Exchange had sought clarification from Pansari Developers Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Consolidated Balance sheet statement not submitted -2. Consolidated Profit and Loss Statement not…

Read More

Granules India Limited

Granules India Limited has informed the Exchange regarding a press release dated December 22, 2025, titled “Granules Pharmaceuticals Inc. Receives FDA Tentative Approval for Generic Amphetamine Extended-Release Orally Disintegrating Tablets (ADZENYS XR-ODT®)”. |SUBJECT: Press Release Source link

Read More